申请人:Mitsubishi Pharma Corporation
公开号:EP1310488A1
公开(公告)日:2003-05-14
The present invention provides a compound represented by the formula (I)
wherein ring A is benzene, cyclohexane, pyridine, piperidine or a derivative thereof, imidazole or a derivative thereof and the like, ring B is benzene, cyclohexane, pyrrole or a derivative thereof, furan, thiophene and the like, R1, R2 and R3 are each hydrogen, alkyl, halogen, hydroxyl group, alkoxy and the like, W is hydrogen, alkyl or hydroxycarbonylalkyl, X is halogen, cyano, nitro and the like, X' is hydrogen, halogen and the like, and Y is alkyl, hydroxyalkyl, hydroxycarbonylalkyl, aminoalkyl and the like, a salt thereof, and a pharmaceutical agent containing the compound. The compound of the present invention shows a superior inhibitory effect on the proliferation of activated lymphocyte and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
本发明提供了一种由式(I)表示的化合物
其中环 A 是苯、环己烷、吡啶、哌啶或其衍生物、咪唑或其衍生物等,环 B 是苯、环己烷、吡咯或其衍生物、呋喃、噻吩等,R1、R2 和 R3 分别是氢、烷基、卤素、羟基、烷氧基等,W 是氢、烷基或羟基羰基烷基,X 是卤素、氰基、硝基等、W为氢、烷基或羟基羰基烷基,X为卤素、氰基、硝基等,X'为氢、卤素等,Y为烷基、羟基烷基、羟基羰基烷基、氨基烷基等,其盐以及含有该化合物的药剂。本发明的化合物对活化淋巴细胞的增殖有很好的抑制作用,可作为预防或治疗各种自身免疫性疾病的药物。